Antibodies News and Research

RSS
SARS-CoV-2 mutations impact T-cell recognition of virus

SARS-CoV-2 mutations impact T-cell recognition of virus

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

Risk of E.R. visit or hospitalization 82% lower in mAbs-treated SARS-CoV-2 patients: Study

Risk of E.R. visit or hospitalization 82% lower in mAbs-treated SARS-CoV-2 patients: Study

Researchers develop model for SARS-CoV-2 fusion intermediate that helps membrane fusion

Researchers develop model for SARS-CoV-2 fusion intermediate that helps membrane fusion

A host of mutations could compromise COVID-19 vaccines and antibody therapies

A host of mutations could compromise COVID-19 vaccines and antibody therapies

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Could cow's milk provide some passive immunity against COVID-19?

Could cow's milk provide some passive immunity against COVID-19?

New fluorescent probe can differentiate between B and T lymphocytes

New fluorescent probe can differentiate between B and T lymphocytes

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents

Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents

New technology shows encouraging results for treating osteosarcoma

New technology shows encouraging results for treating osteosarcoma

Nanobody cocktails neutralize SARS-CoV-2 and variants

Nanobody cocktails neutralize SARS-CoV-2 and variants

Broadly cross-reactive antibody to SARS-CoV-2 RBD with robust resistance to mutational escape

Broadly cross-reactive antibody to SARS-CoV-2 RBD with robust resistance to mutational escape

P681 mutation has little impact on transmissibility in the SARS-CoV-2 UK variant, finds study

P681 mutation has little impact on transmissibility in the SARS-CoV-2 UK variant, finds study

Current hygiene guidelines appropriate for UK and SA variants of SARS-CoV-2, study finds

Current hygiene guidelines appropriate for UK and SA variants of SARS-CoV-2, study finds

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

SARS-CoV-2 spike E484K mutation reduces antibody neutralization

SARS-CoV-2 spike E484K mutation reduces antibody neutralization

Researchers work to develop dual antigen COVID-19 vaccine candidate

Researchers work to develop dual antigen COVID-19 vaccine candidate